Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Reaches New 52-Week High - Time to Buy?

Shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $11.34 and last traded at $11.04, with a volume of 134744 shares changing hands. The stock had previously closed at $10.97.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Fresenius SE & Co. KGaA in a research report on Monday, February 3rd.

Fresenius SE & Co. KGaA Stock Down 0.7 %

The business's 50 day moving average price is $10.50 and its 200-day moving average price is $9.58. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. The firm has a market capitalization of $24.82 billion, a PE ratio of 52.90 and a beta of 0.86.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.18 earnings per share (EPS) for the quarter. The firm had revenue of $6.01 billion during the quarter. As a group, equities research analysts forecast that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.